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Abstract
Background: Far-eastern spotted fever (FESF) is an important emerging infectious disease in Northeast Asia. The
laboratory diagnosis of FESF in hospitals is mainly based on serological methods. However, these methods need to
cultivate rickettsial cells as diagnostic antigens, which is both burdensome and dangerous.
Methods: Eleven surface-exposed proteins (SEPs) were identified in our previous study and their recombinant
proteins (rSEPs) fabricated on a microarray were serologically analyzed with seventeen paired sera from patients
suffered from FESF in this study.
Results: All the rSEPs showed sensitivities of between 53% and 82% to acute-phase sera and of between 65% and
82% to convalescent-phase sera, and all the rSEPs except rRplA showed specificities of between 80% and 95%. The
combination assay of two, three, or four of the four rSEPs (rOmpA-2, rOmpB-3, rRpsB, and rSdhB) showed better
sensitivities of between 76% and 94% to the acute-phase sera or between 82% and 100% to the convalescent-phase
sera and acceptable specificities of between 75% and 90%.
Conclusions: Our results suggest that the four rSEPs are more likely candidate antigens for serological diagnosis of
FESF.
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Background
Rickettsia heilongjiangensis, a spotted fever group (SFG)
rickettsia isolated from ticks in 1983 in Heilongjiang
Province of China [1], is the causative agent of Far-eastern
spotted fever (FESF). FESF has been considered as an im-
portant emerging infectious disease in Northeast Asia for
this rickettsiosis has been diagnosed in Northeast of China
[2], east-Siberian and far-eastern regions of Russia [3,4],
and Japan [5]. Most of the patients naturally infected by R.
heilongjiangensis had fever, chills, headache, dizziness, my-
algias, arthralgias, and anorexia after an incubation period
of 4 to 7 days, and later most of the patients appeared with
a macular or maculopapular rash at the site of tick attach-
ment and lymphadenopathy regional to the eschar [4]. Al-
most half of the patients had hepatomegaly accompanied
with an increased alanine aminotransferase and/or aspar-
tate aminotransferase activity [4]. In a murine model, R.
heilongjiangensis caused severe systemic infection with le-
sions in multiple organs (liver, lung, and brain) [6].
So far, the laboratory diagnosis of rickettsioses in hospi-
tals is mainly based on serological methods although cell
culture and molecular tools like PCR or real-time PCR are
applied [7]. Immunofluorescence assay (IFA) is the gold
standard and is used as a reference technique in most la-
boratories [7]. A gold diagnostic standard for rickettsioses,
IFA followed by real-time PCR, has been built in the
French National Reference Center (FNRC) [8]. However,
IFA needs to cultivate rickettsial cells as diagnostic anti-
gens, which is both burdensome and dangerous.
Some efforts have been focused on screening rickettsial
proteins as serodiagnostic antigens of rickettsioses [9,10].
Kowalczewska et al. characterized 20 rickettsial recombin-
ant proteins by enzyme-linked immune sorbent assay
(ELISA) with sera from patients infected by R. typhi or R.
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conorii [10], in which, many surface-exposed proteins
(SEPs) like Adr2, Omp1, PLD, RickA, Sca1, Sca10, and
Sca13 were used. In fact, many SEPs have been found to be
suitable as diagnostic antigens, such as a 56 kDa outer
membrane protein in detection of Orientia tsutsugamushi
infection [11,12] and a surface protein Pap31 in detection of
Bartonella bacilliformis infection [13]. These findings indi-
cate that SEPs are more likely to be diagnostic candidates.
In our previous study, 24 SEPs of R. heilongjiangensis were
identified and their recombinant proteins (rSEPs) fabricated
on a microarray were serologically analyzed and eleven of
them were recognized as major seroreactive proteins and
potential candidate antigens for serological diagnosis of
FESF by sera from mice experimentally infected with R. hei-
longjiangensis [9]. Also, these rSEPs in microarray assay
showed a higher specificity in recognizing R. heilongjiangen-
sis-infected mouse sera compared with that in ELISA [9]. In
the present study, these rSEPs fabricated on a protein
microarray were assayed with paired sera from FESF pa-
tients during the acute and convalescent phase.
Methods
Patient sera
FESF was diagnosed in patients by PCR using whole blood
[14] as well as clinical symptoms consistent with tick-bite
fever, multiple inoculation eschars and cutaneous rash in
hospital. IgG antibody titers of patient sera were deter-
mined by IFA with R. heilongjiangensis antigen as described
previously [9]. Each case of FESF was confirmed by a single
serum with the specific IgG titer of ≥1:128 or the paired
sera with a fourfold or greater increase of the specific IgG
titers. The paired sera were collected from 17 patients suf-
fered from FESF during the acute and convalescent phase.
The acute-phase sera were collected from the patients at
the date of onset of illness, and the convalescent-phase sera
were collected from the same patients approximately two
weeks after the first sampling. Also, 20 sera, collected from
acute febrile patients with uncertain diagnoses and their ti-
ters of IgG antibodies to R. heilongjiangensis being deter-
mined to be less than or equal to 1:8 in IFA, were used as
negative control or as reference sera to assess diagnostic
specificity of the microarray assay in this study.
All of the patient sera were obtained from a hospital
in northeast China. The serum samples of patients were
collected as part of the routine management of patients
without any additional sampling. All patients gave their
informed consent and all patient data were deidentified.
The Institutional Review Board of the Beijing Institute
of Microbiology and Epidemiology approved the re-
search involving human materials.
Preparation of recombinant proteins
Eleven rSEPs of R. heilongjiangensis, including rGroEL,
rOmpA-2, rOmpB-3, rPrsA, rRplA, rRplY, rRpsB, rSdhB,
rSurA, rYbgF, and rRh054_02285, were used in the
present study. The preparation and purification of these
recombinant proteins were described in our previous
study [9,15].
Immunoblotting assay
The purified rSEPs were immunoblotted with the paired
sera from one patient with FESF. Briefly, rSEPs separated
by SDS-PAGE were transferred to polyvinylidene difluoride
(PVDF) membrane. The PVDF membrane was blocked
with 1% [w/v] bovine serum albumin (BSA) in phosphate
buffer saline (PBS, containing 8.1 mM Na2HPO4, 1.9 mM
NaH2PO4, and 154 mM NaCl) at pH 7.4 overnight. Then,
rSEPs on the PVDF membrane were incubated with the
acute- or convalescent-phase serum (1:250 dilution) that
was previously neutralized with E. coli lysate (5 mg/ml) for
1 h. After three washes in PBST (pH 7.4 PBS containing
0.05% [v/v] Tween 20), the PVDF membrane was incubated
with horseradish peroxidase (HRP)-conjugated goat anti-
human IgG (1:5 000 dilution; Beijing CoWin Biotech,
Beijing, China) for 1 h. Following an additional three
washes in PBST, the PVDF membrane was developed using
a diaminobenzidine (DAB) kit (Boster, Wuhan, China).
Fabrication of protein microarray
Each of the purified rSEPs diluted in PBS to a concentra-
tion of 0.3 mg/ml was printed on epoxy slides (CapitalBio,
Beijing, China) in 5 replicate spots as described previously
[16]. Human IgG with serial dilutions (2.5, 5, 10 and
20 μg/ml) was used to fit the internal calibration curves or
as positive controls. BSA in PBS or lysate of E. coli cells
transformed with pET-32a plasmids at a concentration of
0.3 mg/ml was used as negative controls [16]. For quality
control, the microarray slides were incubated with mouse
anti-His tag IgG-Cy5 (SBA, Birmingham, AL) and the
fluorescence intensity (FI) of each protein on the slides was
scanned by GenePix Personal 4100A (Molecular Devices,
Sunnyvale, CA) and analyzed by GenePix Pro 6.0 software
(Molecular Devices, Sunnyvale, CA) [16]. Proteins with a
signal-to-background ratio over 3.0 were used for further
analysis [16].
Analysis of proteins on microarrays by patient sera
The rSEPs on the microarray slide were probed using pa-
tient sera according to previous descriptions [9]. Briefly,
the microarray slide was blocked with 1% [w/v] BSA in
PBS overnight. Then each well on the slide was incubated
with 50 μl of each patient serum (1:50 dilution) that were
previously neutralized with E. coli lysate (5 mg/ml) for 1 h
[16]. After six washes in PBST, the microarray slide was
developed by incubation with goat-anti human IgG-Cy5
(SBA) (1:500 dilution) for 1 h. Following an additional five
washes in PBST and a final wash in deionized water, the
air dried microarray slide was scanned with a GenePix
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Personal 4100A scanner and the scanned images were an-
alyzed by GenePix Pro 6.0. The FI value of each protein
was calculated by averaging the FI values of five replicate
spots, which had been background-subtracted [9].
Microarray data analysis
Human IgG dose-FI value curves were fitted with linear re-
gression analysis using GraphPad Prism 5 software (Graph-
Pad Software, Inc., San Diego, CA). The relative amounts
of specific IgG (RASIgG) to individual rSEPs in each serum
were determined by interpolating the calculated FI value
with the IgG internal calibration curve [17].
The cutoff value for individual rSEPs in the microarray
assay was generated as described previously using Youden’s
index [13]. The reaction was considered positive if the
RASIgG to one rSEP in any of the patient sera was higher
than the cutoff value.
Statistical analysis
The log-transformed IgG titers to R. heilongjiangensis in
IFA and the numbers of rSEPs recognized by FESF pa-
tient sera in microarray assay were analyzed for potential
correlations by linear regression using GraphPad Prism
5 software.
The IgG titer of the convalescent-phase serum divided
by the IgG titer of the acute-phase serum was calculated
as the increased titer for each paired sera. The increase in
RASIgG to each rSEP in each paired sera was calculated
as follows: The increased RASIgG= RASIgG to one rSEP
in the convalescent-phase serum/RASIgG to the same
rSEP in the acute-phase serum.
In paired sera, the correlation between the increase in
IgG titers (log transformed) to R. heilongjiangensis and
the increase in RASIgG to individual rSEPs was analyzed
by linear regression using GraphPad Prism 5 software.
Results
IgG titers of sera determined by IFA
The IgG titers of 17 paired sera from FESF patients were
determined by IFA with R. heilongjiangensis antigen.
Fourteen of these paired sera showed a fourfold or
greater rise in specific IgG titers and the other 3 paired
sera showed high specific IgG titers greater than or
equal to 1:128 (Table 1).
Immunoblotting assay
Eleven rSEPs of R. heilongjiangensis were immunoblotted
by the acute- or convalescent-phase serum from one of
FESF patients (patient 8 in Table 1). As shown in Figure 1,
seven rSEPs (rGroEL, rOmpA-2, rRh054_02285, rRplA,
rRpsB, rSurA, and rYbgF) were recognized strongly by both
acute- and convalescent-phase serum and the rest were rec-
ognized weakly. Seven rSEPs (rGroEL, rOmpA-2, rPrsA,
rRplA, rRpsB, rSdhB, and rYbgF) showed a stronger
staining reaction with the convalescent-phase serum than
with the acute-phase serum.
Quality control of protein microarray
For quality control, the microarray slides printed with
rSEPs were incubated with mouse anti-His tag IgG-Cy5
(SBA, Birmingham, AL) and scanned for their FI values.
The coefficient of variations (CV) was calculated as the SD
of the FI value for each SEP divided by the average FI value.
As a result, the within-slide CV (n = 6) and between-slide
CV (n = 6) of individual rSEPs on the microarray ranged
from 8% to 18%.
Sensitivity and specificity of rSEPs in microarray assay
Internal calibration curve of the microarray was gener-
ated by probing a serial dilution of human IgG solution
with goat-anti human IgG-Cy5 and the FI value of BSA
probed with goat-anti human IgG-Cy5 was set as the
first point of the internal calibration curve. Linear re-
gression analysis revealed that all the calibration curves
gave the good correlation coefficients (r2) ranging from
0.967 to 0.997 (Figure 2).
Eleven rSEPs on the microarray were probed with the
patient sera. As a result (Table 2), all the rSEPs showed
sensitivities of between 53% and 82% in recognizing
acute-phase sera and of between 65% and 82% in recog-
nizing convalescent-phase sera, and all the rSEPs except
rRplA showed specificities of between 80% and 95%. Four
rSEPs (rOmpA-2, rRplA, rRpsB, and rSdhB) showed
Table 1 The IgG titers of paired sera from patient







1 128 512 Fourfold increase
2 64 1024 Fourfold increase
3 256 512 IgG titer ≥128
4 64 256 Fourfold increase
5 32 512 Fourfold increase
6 128 1024 Fourfold increase
7 128 1024 Fourfold increase
8 256 512 IgG titer ≥128
9 32 512 Fourfold increase
10 256 256 IgG titer ≥128
11 64 1024 Fourfold increase
12 64 1024 Fourfold increase
13 64 512 Fourfold increase
14 128 1024 Fourfold increase
15 128 1024 Fourfold increase
16 64 512 Fourfold increase
17 64 1024 Fourfold increase
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sensitivities of ≥71% in recognizing both acute- and
convalescent-phase sera. Also the summary of sensitivities
of each protein to both acute- and convalescent-phase sera
and specificity of each protein was calculated to generally
evaluate its ability as a candidate antigen for diagnosis of
FESF. As a result (Table 2), four rSEPs (rOmpA-2, rOmpB-
3, rRpsB, and rSdhB) scored higher than the rest.
Relationship between specific IgG titers of sera and
seroreactivity of rSEPs
Linear regression analysis revealed a significant positive
correlation between the log-transformed IgG titers to R.
heilongjiangensis in all the patient sera and the numbers
of proteins recognized by these sera (Figure 3, r2 =
0.5381, P <0.0001, n = 54).
In addition, linear regression analysis revealed that sig-
nificant correlations between the increase in the log-
transformed IgG titers to R. heilongjiangensis for paired
sera and the rising in RASIgG to rOmpA-2 (r2 = 0.2621,
P = 0.0356) or rRpsB (r2 = 0.2838, P = 0.0277) in these
sera (Table 3).
Discussion
In our previous study [9], eleven SEPs of R. heilongjian-
gensis were recognized as major seroreactive antigens
and potential candidate antigens for serological diagno-
sis of FESF in microarray assay with R. heilongjiangen-
sis-infected mouse sera. In the present study, their
recombinant proteins fabricated on a microarray were
Figure 1 SDS-PAGE and immunoblotting analysis of the purified rSEPs. Eleven rSEPs were analyzed with SDS-PAGE (A) and immunoblotted
with acute-phase sera (APS) or convalescent-phase sera (CPS) of patient 8 (B). The relative amount of specific antibodies to individual rSEPs in APS or
CPS of patient 8 was calculated in microarray assay (C). Lanes 1 to 11 refer to rGroEL, rOmpA-2, rOmpB-3, rPrsA, rRh054_02285, rRplA, rRplY, rRpsB,
rSdhB, rSurA, and rYbgF, respectively. Lane M refers to protein markers and their relative molecular masses are indicated in kDa on the left.
Figure 2 One example of the internal calibration curves
generated using serial dilutions (0, 2.5, 5, 10 and 20 μg/ml) of
human IgG probed with goat-anti human IgG-Cy5.
Table 2 The sensitivity and specificity of individual rSEPs
on microarray probed with the acute-phase sera (n = 17)
or convalescent-phase sera (n = 17)






rGroEL 65 65 80 209
rOmpA-2 71 82 85 238
rOmpB-3 65 82 90 237
rPrsA 53 76 95 224
rRh054_02285 71 65 90 225
rRplA 71 82 65 218
rRplY 65 82 85 232
rRpsB 71 71 95 236
rSdhB 82 76 90 249
rSurA 59 82 90 231
rYbgF 65 65 90 219
*The summary of sensitivities of each protein to both acute- and
convalescent-phase sera and specificity of each protein was calculated to
evaluate its ability as a candidate antigen for diagnosis of FESF.
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assayed with paired sera from FESF patients so as to iden-
tify potential candidate antigens for serological diagnosis
of FESF, as well as to explore the kinetic change of the
specific antibodies to individual SEPs in FESF patients.
Firstly, these rSEPs were immunoblotted by paired sera
from one FESF patient, and most of them showed a stron-
ger reaction with the convalescent-phase serum than with
the acute-phase serum, which suggested that more specific
antibodies to these SEPs appeared in the convalescent-
phase serum. This could not be quantitatively determined
in the immunoblotting assay. However, the reactivity of
each rSEP with individual sera was quantitatively deter-
mined by the microarray assay. In addition, the FI value of
each protein probed with individual sera was interpolated
with the calibration curve, which minimized variability in
this quantitative determination so as to improve the
within-slide and between-slide analytical precision.
The individual rSEPs were analyzed by both immuno-
blot and microarray assay using the paired sera from
patient 8. All of the rSEPs except OmpB-3 and YbgF,
to which the RASIgG were higher in microarray,
showed a stronger staining reaction in immunoblot
assay (Figure 1B,C). The exception may be due to the
different states of OmpB-3 and YbgF existing in differ-
ent assays. OmpB-3 was stained very lightly in immono-
blot while the RASIgG in the serum detected with
microarray was big, which might be due to the tertiary
structure of OmpB-3 on the microarray slide that might
have exerted a steric effect to promote non-specific ab-
sorption of IgG from the sera, one effect that would not
apply to the denatured OmpB-3 in the immunoblot assay.
YbgF was stained strongly in immunoblot assay while the
RASIgG in microarray assay was small. YbgF was dena-
tured and might provide more epitopes to bind the spe-
cific antibodies in immonoblot assay, while it maintained
its native structure and might provide less epitopes to bind
the specific antibodies in the microarray assay.
In this microarray assay, only 5% to 20% of reference sera
from the acute febrile patients without antibodies to R. hei-
longjiangensis reacted positively to individual rSEPs except
rRplA, suggesting these rSEPs had a good specificity. The
cross-reaction might be caused by the conservative SEPs
such as the ribosomal protein RplA and patients from
whom the reference sera were collected have suffered from
other infection caused by bacteria which shared the conser-
vative SEPs with R. heilongjiangensis. All of these rSEPs
gave a sensitivity of over 65% to the convalescent-phase
sera from FESF patients while five rSEPs (rOmpA-2,
rOmpB-3, rRplA, rRplY, and rSurA) had a higher sensitivity
of 82% to them. However, only rSdhB had a higher sensitiv-
ity of 82% to the acute-phase sera from FESF patients and
the other rSEPs gave sensitivities of only between 53% and
71% to them.
The summary of sensitivity and specificity was calcu-
lated and four rSEPs (rOmpA-2, rOmpB, rRpsB, and
rSdhB) had relatively higher scores. Also we found that
the four rSEPs could recognize 63%, 63%, 74%, and 85% of
the 19 FESF patient sera with lower IFA titer of ≤256 (2, 7,
5, and 5 of these sera have IFA titers of 32, 64, 128, and
256, respectively), respectively. When combination ana-
lysis of the data resulting from two, three, or four of the
four rSEPs was performed (Table 4), and the patient was
diagnosed as having FESF if the serum sample from him
or her is positively recognized by at least one of the rSEPs,
Figure 3 Linear regression analysis to examine potential
relationships between the IgG titers of FESF patient sera
(n = 54) and the numbers of rSEPs recognized by these sera.
The IgG titer of each serum in IFA was log transformed. The analysis
was conducted using GraphPad Prism 5 software (GraphPad
Software, Inc., San Diego, CA).
Table 3 Linear regression analysis to examine potential
relationships between the increased IgG titers to
R. heilongjiangensis and the increased IgG level to
individual rSEPs in paired sera












*Statistically significant (P < 0.05) associations are marked.
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better sensitivities of between 76% and 94% to the acute-
phase sera or between 82% and 100% to the convalescent-
phase sera and acceptable specificities of between 75% and
90% were obtained. Our results suggest that the remark-
able variation in immune recognition patterns for FESF re-
quire multi-antigen combination to cover the different
antibody responses and thus achieve the highest possible
test sensitivity. Serological tests are the easiest methods
for the diagnosis of rickettsiosis but seroconversion is usu-
ally detected 7–15 days after disease onset [18]. Our com-
bination assay could recognize as many as 94% of the
acute-phase sera and hopefully diagnose FESF rapidly at
the early stage of infection. Therefore, the four rSEPs may
be considered as more likely candidate antigens for the
serological diagnosis of FESF, especially rSdhB, with its
sensitivity of 82% to the acute-phase sera and 76% to the
convalescent-phase sera with specificity of 90%. Further-
more, refinement of the production of fusion molecules
comprised of these SEPs and the reaction conditions of
microarray assay described herein may lead to improve
the sensitivity and specificity for the serodiagnosis of FESF.
Epitopes in these proteins can be predicted using bioinfor-
matics method and synthesized to evaluate their ability of
diagnosis of FESF. Then the molecules fused with different
combination of the selected epitopes may show better sen-
sitivities and specificities.
All of these rSEPs except rRh054_02285 and rSdhB
probed with the convalescent-phase sera gave the same
sensitivity or a higher sensitivity than probed with the
acute-phase sera. This is not unexpected since the
convalescent-phase sera had higher titers of antibodies
to R. heilongjiangensis. We noticed that RASIgG to
rRh054_02285 or rSdhB did decrease when probed with
paired sera from some patients, indicating the specific
IgG level to these proteins decreased quickly in some of
these FESF patients during the convalescent phase.
Linear regression analysis revealed a significant posi-
tive correlation between the log-transformed specific
IgG titers of FESF patient sera in IFA and the numbers
of rSEPs recognized by these patient sera in microarray
assay (Figure 3, P < 0.0001). This indicated that specific
IgG levels to individual SEPs might contribute to the
specific IgG titers to R. heilongjiangensis in FESF pa-
tient sera since they were major seroreactive antigens
of R. heilongjiangensis. Moreover, the increase in IgG
titers to R. heilongjiangensis for paired sera and the ris-
ing in RASIgG to rOmpA-2 or rRpsB in these sera
were significantly correlated (Table 3, P < 0.05), indi-
cating that antibodies to OmpA-2 or RpsB contributed
more to the increase in IgG titers to R. heilongjiangen-
sis than antibodies to other SEPs.
In the present study, the number of paired patient sera
tested was small, which may influence the sensitivities and
specificities of these rSEPs. Detection of specific IgM anti-
body to individual rSEPs might improve the sensitivity to
acute-phase sera of FESF patients and unfortunately some
paired patient sera were not enough to do this test. There-
fore, it is necessary to get more serum samples of FESF
patients for this microarray assay in the future.
Conclusions
In conclusion, the eleven SEPs were serologically charac-
terized with paired sera from FESF patients, and four
rSEPs (rOmpA-2, rOmpB-3, rRpsB, and rSdhB) are more
likely candidate antigens for the serological diagnosis of
FESF. In addition, an optimized microarray composed
with the four rSEPs may give an acceptable sensitivity for
serological diagnosis of FESF during both the acute and
convalescent phase.
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Table 4 The sensitivity and specificity of the combination
assays composed of different rSEPs in recognizing the







rOmpA-2&rOmpB-3 82 94 80
rOmpA-2&rRpsB 76 94 80
rOmpA-2&rSdhB 88 94 80
rOmpB-3&rRpsB 82 94 90
rOmpB-3&rSdhB 88 94 80
rRpsB&rSdhB 82 82 85
rOmpA-2, rOmpB-3&rRpsB 88 100 80
rOmpA-2, rOmpB-3&rSdhB 94 100 75
rOmpA-2, rRpsB&rSdhB 88 94 75
rOmpB-3, rRpsB&rSdhB 88 94 80
rOmpA-2, rOmpB-3, rRpsB&rSdhB 94 100 75
Qi et al. BMC Infectious Diseases 2014, 14:332 Page 6 of 7
http://www.biomedcentral.com/1471-2334/14/332
References
1. Lou D, Wu YM, Wang B, Lui GD, Li JZ, Wang W, Han YF: A new member of
the spotted fever group of rickettsiae—Rickettsia heilongjiangensis. Chin J
Microbiol Immunol 1985, 5:250–253.
2. Wu Y, Zhang Z, Wang H, Yang Q, Feng L, Wang J: Investigation on the
epidemiology of Far-East tick-borne spotted fever in the Northeastern
area of China. Chin J Epidemiol 2008, 29(12):1173–1175.
3. Shpynov SN, Fournier PE, Rudakov NV, Samoilenko IE, Reshetnikova TA,
Yastrebov VK, Schaiman MS, Tarasevich IV, Raoult D: Molecular identification
of a collection of spotted fever group rickettsiae obtained from patients
and ticks from Russia. Am J Trop Med Hyg 2006, 74(3):440–443.
4. Mediannikov OY, Sidelnikov Y, Ivanov L, Mokretsova E, Fournier PE,
Tarasevich I, Raoult D: Acute tick-borne rickettsiosis caused by Rickettsia
heilongjiangensis in Russian Far East. Emerg Infect Dis 2004, 10(5):810–817.
5. Ando S, Kurosawa M, Sakata A, Fujita H, Sakai K, Sekine M, Katsumi M, Saitou W,
Yano Y, Takada N, Takano A, Kawabata H, Hanaoka N, Watanabe H, Kurane I,
Kishimoto T: Human Rickettsia heilongjiangensis infection, Japan. Emerg Infect
Dis 2010, 16(8):1306–1308.
6. Duan C, Meng Y, Wang X, Xiong X, Wen B: Exploratory study on
pathogenesis of far-eastern spotted fever. Am J Trop Med Hyg 2011,
85(3):504–509.
7. La Scola B, Raoult D: Laboratory diagnosis of rickettsioses: current
approaches to diagnosis of old and new rickettsial diseases. J Clin
Microbiol 1997, 35(11):2715.
8. Renvoisé A, Rolain JM, Socolovschi C, Raoult D: Widespread use of real‐
time PCR for rickettsial diagnosis. FEMS Immuno Med Microbiol 2012,
64(1):126–129.
9. Qi Y, Xiong X, Wang X, Duan C, Jia Y, Jiao J, Gong W, Wen B: Proteome
analysis and serological characterization of surface-exposed proteins of
Rickettsia heilongjiangensis. PLoS One 2013, 8(7):e70440.
10. Kowalczewska M, Vellaiswamy M, Nappez C, Vincentelli R, Scola BL, Raoult D:
Protein candidates for the serodiagnosis of rickettsioses. FEMS Immuno
Med Microbiol 2012, 64(1):130–133.
11. Jang WJ, Huh MS, Park KH, Choi MS, Kim IS: Evaluation of an
immunoglobulin M capture enzyme-linked immunosorbent assay for
diagnosis of Orientia tsutsugamushi infection. Clin Diagn Lab Immunol
2003, 10(3):394–398.
12. Chao CC, Huber ES, Porter TB, Zhang Z, Ching WM: Analysis of the cross-
reactivity of various 56 kDa recombinant protein antigens with serum
samples collected after Orientia tsutsugamushi infection by ELISA. Am J
Trop Med Hyg 2011, 84(6):967–972.
13. Angkasekwinai N, Atkins EH, Romero S, Grieco J, Chao CC, Ching WM: An
evaluation study of enzyme-linked immunosorbent assay (ELISA) using
recombinant protein Pap31 for detection of antibody against bartonella
bacilliformis infection among the Peruvian population. AmJTrop Med Hyg
2014, 90(4):690–696.
14. Fournier PE, Dumler JS, Greub G, Zhang J, Wu Y, Raoult D: Gene sequence-
based criteria for identification of New rickettsia isolates and description of
rickettsia heilongjiangensis sp. nov. J Clin Microbiol 2003, 41(12):5456–5465.
15. Qi Y, Xiong X, Duan C, Jiao J, Gong W, Wen B: Recombinant protein YbgF
induces protective immunity against Rickettsia heilongjiangensis infection
in C3H/HeN mice. Vaccine 2013, 31(48):5643–5650.
16. Xiong X, Wang X, Wen B, Graves S, Stenos J: Potential serodiagnostic
markers for Q fever identified in Coxiella burnetii by immunoproteomic
and protein microarray approaches. BMC Microbiol 2012, 12:35.
17. Mezzasoma L, Bacarese-Hamilton T, Di Cristina M, Rossi R, Bistoni F, Crisanti A:
Antigen microarrays for serodiagnosis of infectious diseases. Clin Chem
2002, 48(1):121–130.
18. Brouqui P, Bacellar F, Baranton G, Birtles RJ, Bjoersdorff A, Blanco JR, Caruso G,
Cinco M, Fournier PE, Francavilla E, Jensenius M, Kazar J, Laferl H, Lakos A, Lotric
Furlan S, Maurin M, Oteo JA, Parola P, Perez-Eid C, Peter O, Postic D, Raoult D,
Tellez A, Tselentis Y, Wilske B: Guidelines for the diagnosis of tick-borne
bacterial diseases in Europe. Clin Microbiol Infect 2004, 10(12):1108–1132.
doi:10.1186/1471-2334-14-332
Cite this article as: Qi et al.: Microarray of surface-exposed proteins of
rickettsia heilongjiangensis for serodiagnosis of Far-eastern spotted fever. BMC
Infectious Diseases 2014 14:332.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Qi et al. BMC Infectious Diseases 2014, 14:332 Page 7 of 7
http://www.biomedcentral.com/1471-2334/14/332
